The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women

The PAI-1 4G/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women

Background: Plasminogen activator inhibitor type 1 (PAI-1) is an important regulator of fibrinolysis. A common deletion polymorphism that results in a sequence of 4G instead of 5G in the promoter region of the gene is associated with a small increase in the risk of venous thromboembolism. Its potent...

Full description

Bibliographic Details
Main Authors: Said, J., Tsui, R., Borg, A., Higgins, J., Moses, Eric, Walker, S., Monagle, P., Brennecke, S.
Format: Journal Article
Published: 2012
Online Access:http://hdl.handle.net/20.500.11937/45672

Internet

http://hdl.handle.net/20.500.11937/45672

Similar Items